Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.

Evelyn KleinMarion KiechleAdriana JosipovicSophie-Isabelle AndersAurelia NoskeCarolin MoglerAlexander HapfelmeierJohannes Ettl

Published in: Breast cancer research and treatment (2024)

EndoPredict can guide decisions on adjuvant chemotherapy in early luminal breast cancer. EndoPredict risk stratification is also applicable in premenopausal women.

Keyphrases

early breast cancer
breast cancer risk
polycystic ovary syndrome
electronic health record
locally advanced
big data
pregnancy outcomes
postmenopausal women
pregnant women
metabolic syndrome
young adults
type diabetes
deep learning
artificial intelligence